| Drug Name: | Diazoxide (364-98-7) |
|---|---|
| PubChem ID: | 3019 |
| SMILES: | CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl |
| InchiKey: | GDLBFKVLRPITMI-UHFFFAOYSA-N |
| Therapeutic Category: | Antihypertensive Agents, Cardiovascular Agents, Vasodilator Agents |
| Molecular Weight (dalton) | : | 230.676 |
| LogP | : | 1.8726 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 58.53 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Phenytoin (57-41-0) | Seizure Control Lost | Antagonistic | diazoxide increases the metabolism and the clearance of phenytoin from the body. The half-life of diazoxide is possibly reduced by phenytoin | Drug interaction: diazoxide and diphenylhydantoin |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category